Budget Amount *help |
¥3,120,000 (Direct Cost: ¥2,400,000、Indirect Cost: ¥720,000)
Fiscal Year 2016: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2015: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2014: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
Outline of Final Research Achievements |
Our research plan was obliged to modify by technical issues. First, we injected the adenoviral vector into the round window in guinea pig not mouse, because it was difficult for us to inject into the round window in mouse. Second, deafening was demonstrated by gentamicin and ethacrynic acid not cisplatin because of our laboratory environment.Auditory thresholds at one month after deafening were protected by adenoviral mediated overexpression of Tis21, but not at two weeks. The number of spiral ganglion cells in treated group at two weeks and one month after deafening was maintained compared to that in non-treated group. Our results showed Tis21 had an important role to protect spiral ganglion cells against drug-induced hearing loss in guinea pig
|